- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Placebo and DA-9701
Total 42464 results
-
Novartis PharmaceuticalsTerminatedChronic Spontaneous Urticaria | Cold Urticaria | Cholinergic UrticariaGermany
-
Marinus PharmaceuticalsActive, not recruitingTuberous Sclerosis ComplexUnited States, Spain, United Kingdom, Israel, Italy, Germany, France, Canada
-
University of EdinburghCompleted
-
Butantan InstituteValneva Austria GmbHCompleted
-
ApnimedActive, not recruiting
-
Provention Bio, a Sanofi CompanyActive, not recruitingDiabetes Mellitus, Type 1United States, Belgium, Canada, Czechia, France, Germany, Poland, United Kingdom
-
Vanda PharmaceuticalsMayo ClinicCompletedHealthy VolunteerUnited States
-
Xiao Jing (Iris) WangMayo ClinicEnrolling by invitation
-
GlaxoSmithKlineCompleted
-
Novo Nordisk A/SCompletedGrowth Hormone Disorder | Adult Growth Hormone DeficiencyFrance
-
Peking University People's HospitalActive, not recruitingThyroid Associated OphthalmopathyChina
-
Innovent Biologics (Suzhou) Co. Ltd.TerminatedCOVID-19United States
-
CSL BehringCompletedNoncystic Fibrosis Bronchiectasis (NCFB)United Kingdom, Germany
-
CSL BehringCompletedDiabetic Kidney Disease (DKD)United States, Australia, New Zealand, Puerto Rico, Canada, Israel
-
Yangshengtang Co., LtdSyneos HealthCompletedChronic Hepatitis BAustralia
-
Prothena Biosciences Ltd.TerminatedPrimary Systemic (AL) AmyloidosisUnited States, Spain, Israel, Canada, Poland, Netherlands, France, Germany, United Kingdom, Belgium, Denmark, Greece, Australia, Austria, Italy
-
AstraZenecaCompleted
-
Ball State UniversityCompleted
-
BioNTech SEShanghai Fosun Pharmaceutical Industrial Development Co. Ltd.Completed
-
Eli Lilly and CompanyCompletedObesity | OverweightUnited States, Puerto Rico
-
National Institute of Allergy and Infectious Diseases...CompletedIndolent Systemic MastocytosisUnited States
-
Altimmune, Inc.CompletedHealthy VolunteersUnited States
-
AmgenCompletedA Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of CCX168 in Healthy ParticipantsVasculitis | Systemic Lupus Erythematosus (SLE)Switzerland
-
Intrommune TherapeuticsCompletedPeanut AllergyUnited States
-
LEO PharmaCompletedAtopic DermatitisBelgium, France, Germany, Poland, United Kingdom, Czechia, Spain
-
Immune Biosolutions IncCompletedCOVID-19South Africa, Ukraine
-
Regeneron PharmaceuticalsCompleted
-
TakedaCompletedHealthyColombia, Singapore, Thailand, Puerto Rico
-
LEO PharmaCompletedAtopic DermatitisUnited States, Denmark, United Kingdom, Korea, Republic of, Canada, Italy, Australia, Poland, Russian Federation
-
Z Factor LimitedHammersmith Medicines Research; Centessa Pharmaceuticals plcTerminatedAlpha1 Anti-Trypsin DeficiencyUnited Kingdom
-
TrueBinding, Inc.Withdrawn
-
ArdelyxCompletedHyperkalemiaUnited States
-
Keymed Biosciences Co.LtdCompletedModerate-to-severe Atopic DermatitisChina
-
MacroGenicsNational Institute of Allergy and Infectious Diseases (NIAID)CompletedWest Nile VirusUnited States
-
Astellas Pharma Global Development, Inc.VicalCompletedKidney Transplantation Cytomegalovirus (CMV) Negative RecipientsUnited States, Australia, Canada, France, Germany, Spain
-
BioCryst PharmaceuticalsCompletedParoxysmal Nocturnal HemoglobinuriaUnited Kingdom, Austria, South Africa
-
Stalicla SACompletedAutism Spectrum DisorderUnited States
-
T-Balance Therapeutics GmbHCompletedAllergic Asthma | Allergy to House Dust MiteGermany
-
Charite University, Berlin, GermanySanofi; Proinnovera GmbHCompletedChronic Spontaneous Urticaria | Recurrent AngioedemaGermany
-
National Hellenic Research FoundationTheracell Advanced BiotechnologyCompletedAging | Oxidative Stress | Well AgingGreece
-
Akesobio Australia Pty LtdCompletedCoronavirus Disease 2019 (COVID-19)New Zealand
-
Applied Biology, Inc.CompletedCovid19 | SARS (Severe Acute Respiratory Syndrome)Brazil
-
ShireCompletedHypoparathyroidismUnited States, Denmark, Canada, Hungary, United Kingdom, Belgium, France, Italy
-
Jiangsu HengRui Medicine Co., Ltd.Enrolling by invitationHormone Receptor Positive,Human Epidermal Receptor 2 Negative, Node-positive, High Risk, Early Stage,Female Breast CancerChina
-
Altimmune, Inc.Biomedical Advanced Research and Development AuthorityCompleted
-
OctapharmaTerminatedDermatomyositisRussian Federation
-
Inmunotek S.L.CompletedUrinary Tract Infection BacterialSpain, United Kingdom
-
Comercial Quimica Masso, S.AUniversité Catholique de LouvainCompleted
-
Imperial College LondonCompletedObesity | Appetite RegulationUnited Kingdom